Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 6 Relation between anxiety “Hamilton Anxiety Rating Scale” and different variables

From: Hydroxychloroquine non-availability during COVID-19 pandemic and its relation to anxiety level and disease activity in rheumatoid arthritis and lupus patients: a cross-sectional study

 

OR

P

Group I (RA)

 Age

0.98

0.13

 Sex

1.1

0.17

 Marital state

1.5

0.18

 Disease duration

0.92

0.12

 HCQ stoppage

1.9

0.03*

 Duration of stoppage

3.8

0.017*

 CDAI

1.09

0.01

Group II (SLE)

 Age

2.1

0.02*

 Sex

0.45

0.09

 Marital state

0.9

0.17

 Disease duration

0.98

0.06

 HCQ stoppage

1.6

0.03*

 Duration of stoppage

4.2

0.04*

 SELENA

1.1

0.02*

  1. CDAI clinical disease activity index, RA rheumatoid arthritis, SELENA safety of estrogens in systemic lupus erythematosus national assessment, SLE systemic lupus erythematosus, HCQ hydroxychloroquine
  2. Logistic regression test
  3. *Significant P value if p < 0.05
Back to article page